Indian Govt panel approves country’s first indigenous vaccine for cervical cancer for aged 9-26 years

The subject expert committee meeting that was scheduled today to discuss Serum Institute of India’s (SII) indigenously developed Quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer, has recommended regular market authorisation for above 9 to 26-year-old male and female, according to sources. (ANI)

(With inputs from health)

[title_words_as_hashtags